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INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of pediatric chronic liver disease in North America. Data from the US National Health and Nutrition Examination Survey (NHANES) show elevated serum alanine aminotransferase (ALT) to be prevalent in 8 % of adolescents 12 -19 years of age and Association Between Metabolic Syndrome and Liver Histology Among Children With Nonalcoholic Fatty Liver Disease histology-based population prevalence estimates are 8 % among children aged 2 -19 years ( 1, 2 ) . Th e World Health Organization introduced the term " metabolic syndrome " in 1998 to label a constellation of cardiovascular risk factors that are associated with insulin resistance ( 3 ) . Th e component features of metabolic syndrome (MetS) are central obesity, elevated blood pressure, atherogenic dyslipidemia, insulin resistance, proinfl ammatory state, and prothrombotic state ( 4 ) . In adults, nonalcoholic steatohepatitis (NASH) is considered the hepatic manifestation of MetS ( 5 ) . MetS is an independent predictor of steatosis, fi brosis, and NASH on liver biopsy among adults with NAFLD ( 6 -8 ) .
Evidence for a relationship between MetS and NAFLD in children is emerging. Th e Korean National Health and Nutrition Examination Survey found participants aged 10 -19 years with three or more risk factors for MetS had an odds ratio of 6.2 (95 % CI 2.3 -16.8) for an elevated serum ALT, which they used as an indicator of fatty liver ( 9 ) . More recently, a case -control study of overweight children with biopsy-proven NAFLD and age-, sex-, and obesity-matched controls found that children with NAFLD were signifi cantly more likely to have MetS than obese controls without evidence of fatty liver disease (50 vs. 15 % , P < 0.001) ( 10 ) . A single center study from Italy reported MetS to be present in 65.8 % of children (3 -18 years) with biopsy-proven NAFLD and found grade of fi brosis (fi brosis was absent in 33 % and none of the subjects had cirrhosis) to be the only histological feature significantly associated with MetS on univariate analysis ( 11 ) . It is noted that the criteria used to defi ne MetS in these studies was not uniform as a consensus on the defi nition of this syndrome in children remains in evolution.
Th e National Institute of Diabetes and Digestive and Kidney Diseases, with additional support from the National Institute of Childhood Health and Human Development, funded a Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) beginning in 2002 to assess the etiology, natural history, and therapy of NAFLD ( 12 ) . Th e prospective, multicenter ascertainment of clinical data concurrent with liver histology for the NASH CRN provides a unique opportunity to study the relationship between clinical variables and specifi c histological features of NAFLD ( 13 ) . Th e aim of this study is to evaluate the association between features of MetS and liver histology among children and adolescents with NAFLD enrolled in the NASH CRN. Th e study hypothesis is that features of MetS, correlates of risk for development of premature coronary artery disease and diabetes mellitus, may correspond to increased severity of particular histological features of NASH among children and adolescents with NAFLD.
METHODS

Study sample
Th e treatment of NAFLD in children (TONIC) and NAFLD Database studies have Institutional Review Board approval at each of the eight clinical centers participating in the NASH CRN (see Supplementary Appendix A online). Written consent was obtained from a parent or guardian and written assent obtained from all children 8 years and older before participation. Th e NAFLD Database is an observational study of patients 2 years and older and TONIC is a phase III, double-masked, randomized, placebocontrolled trial of metformin and vitamin E in children between the ages 7 and 17 years with NAFLD ( 13, 14 ) . Exclusion criteria for both studies include signifi cant alcohol intake, other chronic liver diseases, history of parenteral nutrition, bariatric or hepatobiliary surgery, HIV infection, or short bowel syndrome. Participants in TONIC, but not NAFLD database, were required to have a baseline serum ALT value > 60 U / L. Additional exclusion criteria for the TONIC trial include diagnosis of diabetes mellitus, cirrhosis, use of drugs associated with NAFLD, anti-diabetic or anti-NAFLD drugs, metabolic acidosis, and renal dysfunction (these exclusion criteria do not apply to NAFLD database participants). Enrollment for the NAFLD database began in September 2004 and TONIC in August 2005. Participants from both studies, aged 6 -17 years, were eligible for inclusion if they had baseline clinical data to evaluate features of the metabolic syndrome within 6 months of liver biopsy (only baseline, pre-treatment liver biopsies were used from children enrolled in the TONIC trial). Liver biopsy specimens underwent central uniform review by the Pathology Committee of the NASH CRN.
Clinical data
Demographic data were obtained via structured interview and questionnaires. Height, weight, waist, and hip measurements were taken in duplicate with patients standing and wearing light clothing. Height and weight were measured without shoes to the nearest 0.1 cm and 0.1 kg, respectively. Body mass index (BMI) was calculated as the weight (kg) divided by the height (m) squared. BMI percentile was determined according to age and gender based on data from the Centers for Disease Control and Prevention ( 15 ) . Waist measurement was taken at the midpoint between the highest point of the iliac crest and the lowest part of the costal margin. Hip measurement was taken at the fullest part of the hips. Resting blood pressure (mm Hg) was measured from an upper extremity using an appropriately sized cuff and an automated sphygmomanometer.
Laboratory assays
Fasting whole blood samples were obtained via venipuncture following an (mg / dl), total cholesterol (mg / dl), HDL cholesterol (mg / dl), LDL cholesterol (mg / dl), overnight fast of 12 h and processed for plasma and serum within 2 h. Th e following laboratory assays were included at individual clinical centers: ALT (U / L), AST (U / L), triglycerides fasting insulin ( μ U / ml), fasting glucose (mg / dl), and HbA1c ( % ). Fasting insulin and glucose values were used to determine the homeostatic model assessment of insulin resistance (HOMA-IR) and the Quantitative Insulin Sensitivity Check Index (QUICKI) ( 16, 17 
PEDIATRICS
Pediatric Metabolic Syndrome and NAFLD
Steatosis (grade 0 ( < 5 % macrovesicular fat in hepatocytes), grade 1 (5 -33 % ), grade 2 (34 -66 % ), grade 3( > 66 % )), portal infl ammation (0 -2), lobular infl ammation (0 -3), hepatocellular ballooning (0 -2), and fi brosis (stage 0, stage 1a (mild perisinusoidal), stage 1b (moderate perisinusoidal), stage 1c (portal / periportal fi brosis only), stage 2 (zone 3 and periportal), stage 3 (bridging fi brosis), stage 4 (cirrhosis)). A NAFLD activity score (NAS) was tabulated by summing the scores for steatosis, lobular infl ammation, and ballooning degeneration (1 -8 score possible). For regression analyses, all fi brosis stage 1 (1a, 1b, and 1c) biopsies were combined and treated as stage 1, and stage 3 and 4 biopsies were combined and treated as stage 3, advanced fi brosis and a categorical NAS score was defi ned as: 0 = 1 -3 (reference), 1 = 4 -5, and 2 = 6 -8.
In addition to determining the NAS score, an overall diagnostic categorization was determined for each case: " Not NASH " , " Borderline " or suspicious for NASH with a zone 3 or zone 1 pattern, or " Defi nite NASH " ( 19 ) . " Defi nite NASH " was unequivocally diagnostic of steatohepatitis, whereas the category of " Not NASH " encompasses cases of NAFLD in which the changes are so mild or non-specifi c that more specifi c classifi cation cannot be made ( 20 ) . Th e intermediate category of " Borderline zone 3 " was created for cases that had some, but not all, histological features of steatohepatitis. " Borderline zone 1 " was used for cases that fi t the zone 1 pattern of injury previously described in children and had a portal (Zone 1) predominant pattern of injury ( 21 ) .
Defi nitions and reference standards for metabolic syndrome
We used criteria for defi ning the presence of MetS as previously published ( 4 ). Gender-and age-specifi c criteria were used to defi ne presence of the following MetS components: central obesity (waist circumference > 102 cm for males, > 88 cm for females) ( 22 ) , high systolic blood pressure (SBP) and / or diastolic blood pressure (DBP) ( > 95th percentile for age, sex, and height) ( 23 ), low HDL cholesterol ( < 5th percentile for age and race / ethnicity) ( 24 ) , high triglycerides (TG) ( > 95th percentile for age and sex) ( 25 -27 ) and impaired fasting glucose (IFG, fasting glucose ≥ 100 mg / dl) ( 28 ) . Pre-existing diagnosis or treatment for hypertension (HTN), high triglycerides or type 2 diabetes was also assessed from patient ' s baseline clinical history. As defi ned by the National Cholesterol Education Program Adult Treatment Panel III (ATP) for adults, children were classifi ed as having the metabolic syndrome if they met 3 or more of the above criteria ( 4, 22, 29 ) . Results for HOMA-IR and QUICKI were analyzed as additional markers of insulin resistance.
Th e signifi cance of the relationship between MetS and ethnicity groups and baseline characteristics or histology was determined from a Wilcoxon two-sample test for continuous variables, and either a χ 2 test for non-ordered categories, a Cochran-Armitage trend test for ordered categories, Fisher ' s exact test, or binary or multinomial logistic regression for categorical variables ( 30, 31 ) . Adjusted odds ratios or cumulative odds ratios of each categorical histological feature with the presence of a component of MetS were estimated from either a logistic (for binary outcomes), multinomial or ordinal logistic regression model. P values were determined from a likelihood ratio test. If the assumption of a rank outcome was met, then an ordinal logistic regression model was used (steatosis, fi brosis, NAS); otherwise, the multinomial logistic model was used (NAFLD pattern) ( 32, 33 ) . Regression models presented were adjusted for sex, ethnicity (Hispanic / not), age group (6 -11, 12 -14, 15 -17 years), puberty (yes / no). An ethnicity by risk factor interaction term was included in the model if the interaction was signifi cant ( P 0.01) and quantitative. Including BMI z -score in the models did not signifi cantly improve model fi t, so this covariate was dropped. However, as BMI z -score had a highly signifi cant correlation with fi brosis, additional analyses including BMI z -score as a covariate were computed for fi brosis on each component of MetS to test whether associations were independent of BMI z -score. All analyses were based on baseline data available through August 2009 and were performed using SAS statistical soft ware (version 9.1; SAS Institute, Cary, NC) and STATA (release 10.0; Stata Corp, College Station, TX) soft ware. P values presented are two-sided and have not been adjusted for multiple comparisons.
RESULTS
Of the 123 / 195 (63 % ) children in NAFLD Database with liver biopsies that underwent central review, 37 were excluded because they were not within 6 months of clinical data. All of the 173 (100 % ) children in TONIC with liver biopsies who underwent central review were within 6 months of clinical data. One child was excluded for age < 6 years and four were excluded for absence of steatosis on liver biopsy, leaving a total of 254 children with NAFLD eligible for study inclusion. Characteristics of children included in this study are summarized in Table 1 . Overall, 65 (25.6 % ) met criteria for diagnosis of MetS. Among children with MetS, there was a higher proportion of females who were older in age and pubertal (Tanner stage 2 -4). Race / ethnicity did not diff er between children with and without MetS. Measures of obesity were more severe among children with MetS (higher BMI, BMI z -score, and waist and hip circumferences). Children with MetS had a higher prevalence of previously diagnosed and / or treated diabetes, hyperlipidemia, and hypertension. As anticipated, children with MetS had higher mean values of blood pressure, triglycerides, and HOMA-IR with lower mean values of HDL cholesterol and QUICKI. Frequency and distribution of the individual components of MetS are shown in Figure 1 . Among children with NAFLD, 33 (13.5 % ) had no features of MetS and only two (0.8 % ) had all fi ve features present. Central obesity (67.1 % ) and hypertension (44.6 % ) were the most prevalent MetS components in this study population. About one quarter of children with NAFLD had dyslipidemia. Impaired fasting glucose was the least prevalent (12.2 % ) of the MetS features.
Because of the high percentage of children of Hispanic ethnicity in the study population, the prevalence of MetS features was evaluated according to ethnicity to determine if any important diff erences were observed. Hispanic children ( n = 153) had no diff erence in measures of obesity (prevalence of central obesity 66.5 vs. 68.0 % , P = 0.80) compared with non-Hispanic children ( n = 101). Th e prevalence of hypertriglyceridemia was lower among children of Hispanic ethnicity (22.9 vs. 33.3 % , P = 0.07), Prevalence of IFG did not diff er according to ethnicity, but severity of insulin resistance by fasting insulin (43.2 ± 52.7 μ U / ml vs. 28.4 ± 19.1 μ U / ml, P = 0.003), HOMA-IR (9.8 ± 13.0 vs. 6.2 ± 4.2, P = 0.003), and QUICKI (0.30 ± 0.04 vs. 0.31 ± 0.04, P = 0.003) was greater among Hispanic children.
Th e frequency and severity of histological features of NAFLD was compared among children with and without MetS ( Table 2 ) . Severity of steatosis, hepatocellular ballooning, presence of advanced fi brosis, NAFLD pattern, and NAS were all signifi cantly associated with a diagnosis of MetS aft er adjustment for sex, age, ethnicity, and Tanner stage. Th e risk of MetS was greatest among those with severe steatosis (OR = 2.85 for grade 3 vs. grade 1 steatosis, P = 0.001). Th e COR was 2.11 ( P = 0.008) when comparing each level of steatosis to the ones before it. Higher levels of hepatocellular ballooning were signifi cantly associated with MetS (OR = 2.01, P = 0.03). Th ere was no signifi cant diff erence in the association of MetS with the overall category of fi brosis, but those with advanced fi brosis (stage 3 / 4) had an OR for MetS of 3.21 ( P = 0.04) vs. those without fi brosis (stage 0). Borderline zone 1 or defi nite NASH 
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Pediatric Metabolic Syndrome and NAFLD only other MetS feature associated with fi brosis stage was lower HDL cholesterol (COR = 0.97, P = 0.04), though insulin resistance, as measured by fasting insulin (COR = 1.03, P = 0.002), HOMA-IR (COR = 1.15, P = 0.001), and QUICKI (COR = 0.90, P = 0.002) were associated with this histological feature. When the model included BMI z -score as an additional adjustment factor, an association with central obesity and increased severity of fi brosis remained as defi ned by the waist hip ratio (COR = 1.74, P = 0.007), as well as insulin resistance measured by fasting insulin, HOMA-IR and QUICKI (COR = 1.03, P = 0.008, COR = 1.14, P = 0.006 and COR = 0.92, P = 0.03, respectively). Th e association with lower HDL cholesterol no longer remained signifi cant (COR = 0.97, P = 0.08).
Although the presence of MetS was predictive of a higher NAS (COR = 2.12, P = 0.009), associations were also present with higher triglyceride levels (COR = 1.003, P = 0.04), lower HDL cholesterol levels (COR = 0.97, P = 0.02), and a diagnosis of hypertension (COR = 1.65, P = 0.04). Insulin resistance as measured by QUICKI (COR = 0.86, P < 0.001) was also associated with NAS ( Figure 2c ).
Hepatocellular ballooning was associated with the presence of central obesity (OR = 2.15, P = 0.01), BMI z -score (OR = 2.17, P = 0.04), and higher triglycerides (OR = 1.0043, P = 0.02). Insulin resistance as measured by QUICKI (OR = 0.90, P = 0.01) was also associated, and for non-Hispanics, IFG was predictive of hepatocellular ballooning (OR = 14.31, P = 0.01) ( Figure 2d ).
In addition to the strong association between diagnosis of MetS and borderline zone 1 or defi nite NASH vs. not NASH patterns, certain component features of MetS were also associated with the NAFLD pattern as shown in Table 3 . Central obesity was highly associated with borderline zone 1 or defi nite NASH patterns (OR = 2.71, P = 0.02 and OR = 4.08, P = 0.001 vs. not NASH, respectively). HTN was predictive of borderline zone 1 pattern vs. not NASH (OR = 3.02, P = 0.006). Although IFG was not signifi cantly associated with NAFLD pattern, severity of insulin resistance (Fasting insulin, HOMA-IR, and QUICKI) were associated with the defi nite NASH pattern vs. not NASH (OR = 1.052, P = 0.01, OR = 1.283, P = 0.007, and OR = 0.786, P < 0.001, respectively).
DISCUSSION
In adults, NASH is considered the hepatic manifestation of the metabolic syndrome ( 5 ) . Although adult studies of NAFLD have found MetS to be an independent predictor of steatosis, fi brosis, and NASH on liver biopsy, ours is the fi rst study to evaluate the association between components of MetS in children with features of NAFLD histology ( 6 -8,34 ) . Th e potential signifi cance of understanding the association between MetS and NAFLD includes provision of prognostic markers, NAFLD relation to cardiovascular risk factors, insight into disease pathophysiology, and potential targets for therapeutic intervention. Th e potential power of MetS as a prognostic indicator of disease severity in NAFLD lies in the fact that determination of MetS components is relatively non-invasive. Th is may help to identify children at greatest risk for advanced fatty liver disease and facilitate appropriate evaluation of such individuals. Steatosis severity, fi brosis severity, NAFLD Activity Score (NAS), hepatocellular ballooning, and NAFLD pattern were further evaluated to see if the number of MetS features or the severity of individual MetS components had any relationship to these histological variables ( Figure 2 and Table 3 ). In addition to an association with MetS, severity of steatosis was also signifi cantly associated with the severity of certain component features of MetS. Steatosis grade was most strongly associated with severity of HTN (COR = 2.08, P = 0.003). Th e MetS score or total number of features (overall P = 0.05) and central obesity as refl ected by waist hip ratio (COR = 1.48, P = 0.05) were also associated with steatosis severity. Although IFG was not signifi cantly associated with steatosis severity, insulin resistance as measured by QUICKI was (COR 0.928, P = 0.04) ( Figure 2a ) .
As noted earlier, overall severity of fi brosis was not signifi cantly associated with MetS ( Figure 2b ). However, odds of more severe fi brosis were markedly increased if obesity was present as defi ned by BMI z -score (COR = 3.40, P < 0.001) as well as central obesity (COR = 1.78, P = 0.03), increased waist circumference (COR = 1.03, P < 0.001) and increased waist hip ratio (OR = 1.99, P < 0.001). Th e children had zero features of MetS and the majority (77.2 % ) had one to three features present. A diagnosis of MetS (three or more features present) was predictive of steatosis severity, NAS, hepatocellular ballooning and NAFLD pattern (borderline zone 1 or defi nite NASH). Fibrosis stage was not associated with a diagnosis of MetS; however, advanced fi brosis compared with no fi brosis was signifi cant. Th is is in contrast with results of a single-center, Italian study with 120 Caucasian subjects ( 11 ) . In this study, the reported prevalence of MetS was 65.8 % and fi brosis was the only histological feature of NAFLD associated with the presence of MetS (details regarding distribution of the severity of fi brosis were not provided for this study for comparison). Th e signifi cantly lower prevalence Th is study is the largest histology-based study of MetS in children with NAFLD and the only such study, which is prospective, or multi-center, or where liver biopsies were evaluated by a committee of pathologists with expertise in NAFLD histopathology. We applied age-and sex-adjusted normative values in defi ning the component features of MetS and required that these features had been evaluated within 6 months of liver biopsy. Using these criteria, the prevalence of MetS was 25.6 % , central obesity and hypertension (HTN) being the most common of the MetS features observed. In comparison, estimates of MetS in the general population among adolescents 8 to 19 years of age using data from NHANES range from 1.25 to 9.4 % ( 35 -39 ). Only 13.5 % of NAFLD, non-alcoholic fatty liver disease; NAS, NAFLD Activity Score; NASH, nonalcoholic steatohepatitis. a Data are number and percent ( % ) in each category except for the NAFLD Activity Score (NAS). † Odds ratios and P values (two-sided) determined from either a logistic (binary) or a multinomial logistic regression; multiple linear regression analysis used for continuous NAS score. Estimates derived from multivariable regression were adjusted for sex, ethnicity, age (6 -11, 12 -14, 15 -17) , and puberty (yes / no). ‡
Ordinal logistic regression used to determine COR and P value to test for trend, if model assumptions were met. P values in bold type are statistically signifi cant (P < 0.05).
PEDIATRICS
Pediatric Metabolic Syndrome and NAFLD
In addition to an overall diagnosis of MetS, we also evaluated the component features of MetS and their severity to see if these were associated with histological features of NAFLD. Of these, severity of insulin resistance was the component most consistently associated with histological features of NAFLD, showing signifi cant associations with severity of steatosis, fi brosis, NAS, hepatocellular ballooning, and NAFLD pattern. Importantly, fasting glucose values were not signifi cantly associated with any of the histological features in this population of children with NAFLD. Th us while fasting glucose is the most common screening undertaken to assess for insulin resistance, it does not appear adequately sensitive, at least at levels currently recommended for diagnosis of IFG, to distinguish histological features of NAFLD in children. Central obesity was associated with steatosis grade, fi brosis stage, hepatocellular ballooning and NAFLD pattern and HTN with steatosis grade, NAS, and NAFLD pattern. Th e use of adult values for defi nition of central obesity may have resulted in misclassifi cation error, particularly among the youngest children in the study. Th us, rate of MetS in our study population may be related to the criteria used to defi ne MetS. We used age-adjusted normative values for blood pressure and lipids and used the most conservative cutoff values for HDL cholesterol and triglycerides ( < 5th percentile and > 95th percentile, respectively). We also used impaired fasting glucose to defi ne insulin resistance as results for glucose tolerance were not available for the entire study sample. Furthermore, most of the children included in this analysis were from the TONIC study, which excluded those with impaired fasting glucose. Th e conservative criteria used to defi ne MetS in our study may help to account for the associations that were identifi ed with several histological features of NAFLD in contrast to the study by Manco et al. ( 11 ) in which fi brosis was the only histological variable associated with MetS. As the criteria for MetS in this age group remains in fl ux, the prevalence of MetS among children with NAFLD and the strength of the relationship between MetS and features of NAFLD is likely to vary until consensus on the defi nition of MetS in children has been reached. the true impact of central obesity may have been underestimated in our results. Th e potential basis of NAFLD comorbidity with MetS may be common underlying abnormalities present in these conditions such as insulin resistance and oxidative stress. Th e most widely accepted paradigm of NASH pathogenesis is that of the " two-hit hypothesis " in which the primary abnormality, accumulation of triglyceride droplets within hepatocytes, occurs as a consequence of insulin resistance ( 40 ) . Peripheral insulin resistance leads to hyperinsulinemia, which promotes de novo hepatic lipogenesis through upregulation of lipogenic transcription factors, and an increased fl ux of free fatty acids to the liver due to loss of insulin-mediated suppression of lipolysis ( 41, 42 ) . Hepatic export of triglycerides as very low-density lipoprotein may also be impaired ( 43 -45 ) . Following hepatocellular trigylceride accumulation, the steatotic liver is vulnerable to additional insults, the so-call " second hit. " Proposed sources of this secondary injury include oxidative stress, adipocytokines, and gut-derived bacterial endotoxins. Th e pathogenesis of the clustering of metabolic risk factors termed MetS is complex and may not have a single underlying cause, but appears to depend upon the presence of two major factors (excess body fat and metabolic susceptibility), which may be driven by several mediators. Th ese include defects in insulin signaling and mitochondrial oxidative pathways ( 46 ) . Ectopic fat deposition, including NAFLD, may also be an important factor in the pathogenesis of MetS among overweight and obese individuals ( 47 ) .
A recent case -control study compared 150 overweight children with biopsy-proven NAFLD to 150 age-, sex-, and obesity-matched children without evidence of NAFLD and found that, aft er adjustment for age, sex, race, ethnicity, and hyperinsulinemia, children with MetS had an odds ratio of 5.0 (95 % CI 2.6 -9.7) for NAFLD compared with children without MetS ( 10 ) . Th is is the most compelling data to support a signifi cant relationship between NAFLD and MetS, not explicable merely by the coexistence of overweight or obesity in these two conditions, and lend support to the hypothesis that fat accumulation in the liver has an important role in the pathogenesis of other obesity-related comorbidities. While an understanding of the clinical signifi cance of MetS in childhood is still evolving, there are data that show pediatric MetS to be predictive of pre-clinical and clinical cardiovascular disease. Childhood (age 3 -18 years) LDL cholesterol, SBP, BMI, and smoking have been shown to be predictive of intima-medial thickness, a marker of preclinical atherosclerosis, in young adults (ages 24 -39 years) ( 48 ) . Long-term follow-up of participants in the National Heart, Lung, and Blood Institute Lipid Research Clinics (LRC) Princeton Prevalence Study who were included in the Princeton Follow-up Study assessed the association of MetS in childhood with adult cardiovascular disease 25 years later ( 49 ) . In a multivariable analysis, pediatric MetS (OR 14.7, P < 0.0001) and age (OR 1.2, P = 0.03) were signifi cant predictors of cardiovascular disease in adulthood. Th ese data support the concept of pediatric MetS as an important marker for future comorbidity and highlight the importance of further studies to investigate the implications of MetS in this age group, including its relationship with NAFLD.
In conclusion, MetS appears to be common among children with NAFLD, aff ecting approximately one quarter of children enrolled in the NASH CRN. Central obesity and HTN were the most prevalent MetS features present in children with NAFLD. Th e presence of MetS was associated with steatosis, NAS, advanced fi brosis, hepatocellular ballooning, and a diagnosis of borderline zone 1 or defi nite NASH, thus may be useful as a clinical indicator of children who are likely to have more severe histological fi ndings. Of the MetS features, central obesity and insulin resistance (indicated by fasting insulin, HOMA-IR, or QUICKI) were most consistently associated with NAFLD histology. Th ese results indicate that an evaluation for MetS features should be considered in children being evaluated for NAFLD as individually and collectively they may help to identify children with more advanced disease. Future studies will be required to establish the relationship of MetS with long-term prognosis and response to treatment in children with NAFLD.
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